Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMLROMP)

Drug Name
TKM-PLK1 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DMLROMP

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
PLK1 messenger RNA (PLK1 mRNA) TTH4IP0 PLK1_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT02191878) Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma. U.S. National Institutes ofHealth.
2 Clinical pipeline report, company report or official report of Arbutus Biopharma.